RESEARCH STATS
POOL
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
Interactions with Platform & by Email
PARTICIPANTS
Unique # Participated
VALIDATIONS
Responses Validated*
DATA ROOM
EXECUTIVE
CITATIONS
COMPANY
DISCUSSIONS
BRAND/PRODUCT
INSIGHTS
TOTAL
DATA STACK
*Clients have full access to our data room
DATE
SEP 2023
COMPANIES
295
TABLES
154
PAGES
849
EDITION
8
PRICE
USD 5600
CODE
MCP22151
*Engagement stats are ongoing and dynamic
OUR EXPERT PANELS
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
WHY PARTICIPATE?
Expertise to the Power of YOU!
- Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
- Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
- Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
- Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
- Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription
- The Economist
- MIT Technology Review
- Harvard Business Review
Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.
MARKETGLASS
BASIC
- $500/Month/User. Extra Users @ $100/Month/User
- Annual Prepaid Subscription
- Single-User
- 10,000 Data Room Credits/Month
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use MarketGlassTM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
PREMIUM
- $1000/Month/User. Extra Users @ $100/Month/User
- Annual Prepaid Subscription
- One Research Project With One Complimentary Update/Year
- 10-User License
- 10-User Peer-to-Peer Collaborative Features
- 200 Domain Expert Insights (With Name, Company, and Date)
- 50,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
ENTERPRISE
- $2500/Month/User. Extra Users @ $150/Month/User
- Annual Prepaid Subscription
- Four Research Projects With One Complimentary Update/Year
- 25-User License
- 25-User Peer-to-Peer Collaborative Engagements
- 500 Domain Expert Insights (With Name, Company, and Date)
- 150,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
HIGHLIGHTS & REPORT INDEX
What`s New?
» Special discussions on the global economic climate and market sentiment
» Coverage on global competitiveness and key competitor percentage market shares
» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass™ research platform
» Complimentary updates for one year
» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Economic Outlook
The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.
The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.
Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Life Science Tools Market to Reach $258.6 Billion by 2030
The global market for Life Science Tools estimated at US$133 Billion in the year 2022, is projected to reach a revised size of US$258.6 Billion by 2030, growing at aCAGR of 8.7% over the period 2022-2030. Cell Biology, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$82.6 Billion by the end of the analysis period. Growth in the Genomics segment is estimated at 8.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $48.4 Billion, While China is Forecast to Grow at 13% CAGR
The Life Science Tools market in the U.S. is estimated at US$48.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$31.1 Billion by the year 2030 trailing a CAGR of 13% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 8.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.
SELECT PLAYERS
Abbott Laboratories Inc.; Agilent Technologies, Inc.; Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; Bruker Corporation; Carl Zeiss AG; Eppendorf SE; F. Hoffmann-La Roche AG; Hitachi High-Tech Corporation; Illumina, Inc.; Merck KGaA; Oxford Instruments plc; PerkinElmer Inc.; QIAGEN N.V.; Shimadzu Corporation; Thermo Fisher Scientific Inc.
SEGMENTS
» Technology (Cell Biology, Genomics, Proteomics, Other Technologies) » End-Use (Healthcare, Biopharmaceutical Companies, Government & Academics, Other End-Uses)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Middle East » Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
A Prelude to Life Sciences Tools |
Impact of Covid-19 and Global Economic Update |
War & Inflation Supersede COVID-19 as Major Downside Risks for the Global Economy in 2023 & Beyond |
Here’s How Inflationary Pressures Affect the Economy |
Life Science Tools Market Gains Precedence during COVID-19 Pandemic |
Competition |
Players Pursue Product Launch & Innovation to Stay Relevant in Competitive Life Science Tools Market |
Life Science Tools – Global Key Competitors Percentage Market Share in 2023 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for 295 Players Worldwide in 2023 (E) |
Global Market Analysis and Prospects |
Global Life Science Tools Market Appears Primed for Healthy Growth Ahead |
Cell Biology Holds Significant Revenue Stake |
Hospitals Remain Primary End-User Segment |
North America Maintains Front Rank in Global Life Science Tools Market |
Asia-Pacific to Exhibit Impressive Growth |
Salient Drivers Keeping Global Life Science Tools Market in Good Shape |
Technology Trends in the Life Sciences Domain |
Connected Devices, IoT Ecosystems to Transform the Life Science Landscape |
Exponential Intelligence, Quantum Computing and Ambient Technologies to Make Headway |
Cloud Platforms Ease Data Sharing |
Life Sciences to Gain with Blockchain Edge |
AI-enabled Automation to Deliver Tangible Benefits for All |
Cybersecurity Needs Grow for Life Sciences |
Intertwined Factors with Major Implications for Life Science Domain & Related Tools |
Recent Market Activity |
World Brands |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Trends in Life Science Sector Support Demand |
Why Diagnostic Testing is Key to Mitigate Impact of Infectious Diseases? |
3D Cell Culture Transforms Life Sciences Industry |
EXHIBIT: Global 3D Cell Culture Market in US$ Million: 2020 - 2027 |
Increasing Demand for 3D Cell Culture in Drug Discovery |
Use of 3D Cell Culture for Regenerative Medicine |
Proteomics Emerges as an Important Research Tool in Battle against COVID-19 |
Proteomics Profiling to Expedite Drug Discovery |
Proteomics at the Fore with Latest Advances |
Mass Spectrometry (MS) Expands Application of Proteomics |
AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns |
mRNA Technology Gains Spotlight in Life Sciences |
Innovations in Instrumentation Expand Functionality and Drive Adoption of PCR |
Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years |
EXHIBIT: Global qPCR and dPCR Instrumentation Market in US$ Million: 2020-2025 |
Genome Sequencing Experiences Host of Evolutionary Waves |
Greater Integration of Genomic Technologies in the Development of Novel Diagnostics Tests |
Next Generation Sequencing Drives the Market Growth |
R&D Activity Remains Vibrant in NGS |
The Need for Large-scale NGS Data Analysis Pushes for Cloud-enabled Bioinformatics Services |
Single-Cell Spatial Biology Technologies Poised to Emerge as an Integral Aspect of Future Labs |
Rising Application of Whole Genome Sequencing Drives Demand for Faster Secondary Analysis Tools |
Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market Prospects |
EXHIBIT: Global BioPharmaceuticals Market in US$ Billion: 2020 and 2026 |
Liquid Chromatography Drives Growth in New Application Markets |
Innovative HPLC Products Inject New Growth |
Digital Transformation of Life Sciences Sector Improves Efficiency and Productivity |
EXHIBIT: Key Initiators of Digital Transformation in Life Sciences |
Artificial Intelligence offers Multiple Opportunities |
Wearable Devices Gains Popularity |
The Cloud Technology Witnesses Rapid Growth |
VR and E-pharmacy |
Smart Quality |
Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities |
EXHIBIT: Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025 |
Technological Developments and Expanding End-Use Applications to Bolster Growth in Mass Spectrometry |
EXHIBIT: Global Chromatography Market (2022): Percentage Share Breakdown of Value Sales by Chromatography Techniques |
Miniature Mass Spectroscopy Instruments Get Popular |
Increase in Healthcare Spending to Propel Demand for Life Science Tools |
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 |
The Rise of Data Analytics in Life Sciences |
Data Science in Drug R&D |
Data Sharing Emerges as a Significant Trend to Gain Competitive Advantage |
4. GLOBAL MARKET PERSPECTIVE |
World Life Science Tools Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030 |
World Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Government & Academics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
USA Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
JAPAN |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Japan Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
CHINA |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
China Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
EUROPE |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Europe Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
Europe Historic Review for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
FRANCE |
France Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
GERMANY |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
UNITED KINGDOM |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Spain Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Spain 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Spain Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Spain Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Spain 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Russia Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Russia 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Russia Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Russia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Russia 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
ASIA-PACIFIC |
Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
AUSTRALIA |
Australia Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Australia Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Australia 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Australia Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Australia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Australia 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
INDIA |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E) |
India Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
India Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
India 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
India Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
India Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
India 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
SOUTH KOREA |
South Korea Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
South Korea Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
South Korea 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
South Korea Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
South Korea Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
South Korea 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
LATIN AMERICA |
Latin America Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Latin America Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Latin America Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Latin America Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
MIDDLE EAST |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E) |
Middle East Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Middle East Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Middle East 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Middle East Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Middle East Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Middle East 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
AFRICA |
Africa Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Africa Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Africa 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2023 & 2030 |
Africa Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Africa Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Africa 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2023 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com
DIFFERENTIATORS
Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .
What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).
WHAT SETS US APART
FULL STACK DATA ACCESS
- Primary Research Cluster Data
- Influencer Engagement Stats
- Evidence of Primary Research
- List of Companies Engaged
- Hundreds of Pages of Research
- Peer Collaborative Interactions
- Enterprise Data Exchanges
- MarketGlassTM Platform Insider
- Geographic Pricing Dynamics
- Competitive Shares by Country
- Brand Curation & Insights
- Domain Expert Pool
Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.
Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.
Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.
Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.
Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.
Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.
Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.